Skip to main content
Equibles

D. E. Shaw & Co., Inc.

Position in VIR — Vir Biotechnology, Inc.

CIK 1009207 New York, NY
Back to VIR Full portfolio

Position in VIR

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$4,243,146
-$3,083,311 QoQ
Shares Held
416,403
-49.1% QoQ
Ownership
0.246%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#53
of 237 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in VIR Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

D. E. Shaw & Co., Inc. holds $5,139,216,221 across 216 Biotechnology names. VIR ranks #101 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 INSM
INSMED Inc
 5,877,959 $626,707,987
2 ALNY
Alnylam Pharmaceuticals, Inc.
 1,104,109 $332,369,932
3 EXEL
Exelixis, Inc.
 5,551,747 $302,070,554
4 BBIO
BridgeBio Pharma, Inc.
 3,633,007 $270,586,360
5 TGTX
Tg Therapeutics, Inc.
 3,400,808 $186,840,390
6 HALO
Halozyme Therapeutics, Inc.
 2,006,479 $157,047,110
7 AXSM
Axsome Therapeutics, Inc.
 604,753 $148,025,391
8 PTCT
Ptc Therapeutics, Inc.
 1,548,919 $126,345,322

All Filings in VIR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,243,146 416,403
2026-03-31 $7,326,457 817,685
2025-12-31 $300,245 49,792
2025-09-30 $191,422 33,524
2025-06-30 $182,734 36,257
2025-03-31 $3,283,441 506,704
2024-12-31 $3,684,679 502,000
2024-09-30 $6,970,605 930,655
2024-06-30 $8,210,730 922,554
2024-03-31 $6,546,552 646,254
2023-12-31 $7,737,588 769,144
2023-09-30 $8,247,764 880,231
2023-06-30 $1,313,213 53,535
2023-03-31 $1,566,071 67,300
2022-12-31 $1,138,823 44,995
2022-09-30 $285,691 14,818
2022-06-30 $218,736 8,588
2022-03-31 $1,343,355 52,230
2021-12-31 $6,062,859 144,802
2021-09-30 $7,273,323 167,126
2021-06-30 $10,365,099 219,228
2021-03-31 $5,962,290 116,292
2020-12-31 $577,671 21,571